Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

NICE set to block post-Velcade use of Revlimid

Watchdog's new draft guidance does not recommend Celgene blood cancer drug

- PMLiVE

Ferring’s Inna Demidova moves to ELC

Takes up Russia and CIS role at the regulatory affairs specialist

- PMLiVE

Pfizer acquires Baxter Men C and encephalitis vaccines for $635m

Snaps up marketed vaccines and part of Baxter's Austrian manufacturing plant

- PMLiVE

Amgen cuts workforce and facilities despite profit leap

US biopharma plans 12-15 per cent workforce reduction

- PMLiVE

European licence for BMS/Pfizer’s Eliquis in DVT and PE

Anticoagulant catches up with Bayer's Xarelto and Boehringer's Pradaxa

- PMLiVE

Merck Serono enters anti-PD-1 fray

Moves skin cancer antibody candidate into phase II trials

Roche - Basel

Roche wins European approval for new leukaemia drug

Gazyvaro now available for use in treatment of blood cancer in the EU

- PMLiVE

Walgreens’ head of pharmacy to step down

Kermit Crawford plans to retire

PMCPA looks to app to simplify the APBI Code of Practice

Code regulator takes 'digitally-led' approach in partnership with The Earthworks

- PMLiVE

J&J’s Imbruvica wins new cancer indication

FDA backs drug’s use in chronic lymphocytic leukaemia patients with genetic mutation

Novartis building

Novartis’ glaucoma combo cleared in Europe

Simbrinza approved to treat eye condition

- PMLiVE

Reckitt Benckiser confirms pharma spin-off plans

Will separate prescription and consumer health businesses

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links